Johrei Therapy and CBT-I in Facilitating Sleep in ICU Survivors
Comparative-effectiveness of Johrei Therapy and CBT-I in Facilitating Sleep in ICU Survivors
2 other identifiers
interventional
50
1 country
1
Brief Summary
The purpose of this project is to compare the effectiveness of Johrei therapy (JT) and Cognitive-behavioral Therapy for Insomnia (CBT-I) in the treatment of sleep disturbances in survivors of critical illness. Subjects will be recruited following discharge from the Intensive Care Unit (ICU) and followed for 6 weeks. All subjects will undergo objective measurements of sleep quality and duration at baseline and at 6 weeks. Objective measurements will be made by portable (home-based) sleep studies and will wear a watch that measures sleep. Subjective measurements will be performed by sleep questionnaires: PSQI, Epworth sleepiness scale, sleep log, and Stanford Sleepiness Scale which will be performed at baseline, 2 and 6 weeks. A blood draw and urine collection will be done at both baseline and 6 weeks. The central purpose of this proposal is to perform a comparative-effectiveness study of a complementary and alternative approach (Johrei therapy) and CBT-I in the treatment of sleep disturbances in survivors of critical illness. The investigators hypothesize that, in survivors of critical illness, Johrei therapy is superior or comparable to CBT-I in improving sleep quality (Pittsburgh Sleep Quality Index \[PSQI\] and sleep efficiency \[measured by polysomnography\]). A secondary objective is to compare the effect of Johrei therapy and CBT-I on systemic markers of inflammation and urinary biomarkers of sleep and stress. The investigators hypothesize that, in survivors of critical illness, Johrei therapy is superior or comparable to CBT-I in reducing systemic markers of inflammation and urinary biomarkers of sleep and stress. A tertiary objective is to determine whether the presence of insomnia or other sleep characteristics is associated with hospital readmissions within 30-days.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedFirst Submitted
Initial submission to the registry
February 6, 2014
CompletedFirst Posted
Study publicly available on registry
February 11, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2023
CompletedApril 16, 2025
April 1, 2025
9.4 years
February 6, 2014
April 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Pittsburgh Sleep Quality Index (PSQI) (CBT-I, Johrei therapy)
Used to measure sleep quality
2 weeks
Polysomnography (CBT-I, Johrei therapy)
Used to measure sleep efficiency
6 weeks
Pittsburgh Sleep Quality Index (PSQI) (CBT-I, Johrei therapy)
Used to measure sleep quality.
6 weeks
Secondary Outcomes (9)
Actigraphy (CBT-I, Johrei therapy)
Baseline, 2 weeks, 6 weeks
Epworth Sleepiness Scale (ESS) (CBT-I, Johrei therapy)
Baseline, 2 weeks, 6 weeks
Sleep Log (CBT-I, Johrei therapy)
Baseline, 2 weeks, 6 weeks
Stanford Sleepiness Scale (SSS) (CBT-I, Johrei therapy)
Baseline, 2 weeks, 6 weeks
Post Traumatic Stress Disorder (PTSD) Checklist (CBT-I, Johrei therapy)
Baseline, 2 weeks, 6 weeks
- +4 more secondary outcomes
Study Arms (2)
Johrei Therapy
EXPERIMENTAL* 3 sessions per week lasting 30 minutes. * Daily report of bedtime and wake time. Baseline: * Polysomnography * Actigraphy * Questionnaires * Blood draw * Urine collection 2 weeks: * Questionnaires * Actigraphy download * Sleep log reconciliation 6 weeks: * Polysomnography * Actigraphy download * sleep log reconciliation * Questionnaires * Blood draw * Urine collection
Cognitive Behavioral Therapy for Insomnia (CBT-I)
ACTIVE COMPARATOR* 1 session per week for a total of 6 weeks with the option of 2 additional sessions. * Daily report of bedtime and wake time. Baseline: * Polysomnography * Actigraphy * Questionnaires * Blood draw * Urine collection 2 weeks: * Questionnaires * Actigraphy download * Sleep log reconciliation 6 weeks: * Polysomnography * Actigraphy download * sleep log reconciliation * Questionnaires * Blood draw * Urine collection
Interventions
\- Therapy session administered by a clinical psychologist using web-based video conferencing software. Therapy sessions will include: * Sleep restriction therapy * Stimulus control instructions * Sleep hygiene education
* Therapy will be administered by a senior Johrei administrator at the University of Arizona or the patient's residence. * Therapy sessions will consist of 3 sessions per week lasting 30 minutes each. * Therapist will wash his hands and and pray for 1 minute while facing the subject at a distance. * Therapy will be administered without physical contact. * During therapy the administrator will sit adjacent to the patient and channel energy from his palm towards the patient.
Eligibility Criteria
You may qualify if:
- Medical and surgical patients with recent critical illness warranting ICU stay.
You may not qualify if:
- Patients who are considered too unstable to undergo this investigation by their primary physician
- Patients with severe debilitating neurological disease ( end-stage Alzheimer's, large stroke, or other debilitating neurological disease) that renders patients incapable of providing informed consent
- Pregnancy (All inpatients with recent ICU stay of the childbearing age would have had a pregnancy test while in the hospital).
- Patient's residence is beyond a 20 mile radius from University of Arizona.
- Patient does not have a reliable way of communication such as a cellphone or telephone line.
- Being discharged to a nursing home of skilled nursing facility.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Arizonalead
- The Johrei Institutecollaborator
Study Sites (1)
University of Arizona Medical Center
Tucson, Arizona, 85724, United States
Related Publications (1)
Buzzetti RA, Hinojosa-Kurtzberg M, Shea TJ, Ibuki Y, Sirakis G, Parthasarathy S. Effect of Johrei therapy on sleep in a murine model. Explore (NY). 2013 Mar-Apr;9(2):100-5. doi: 10.1016/j.explore.2012.12.004.
PMID: 23452712BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sairam Parthasarathy, MD
University of Arizona
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 6, 2014
First Posted
February 11, 2014
Study Start
January 1, 2014
Primary Completion
June 1, 2023
Study Completion
June 1, 2023
Last Updated
April 16, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share
There is no plan to share IPD information.